Uranium Royalty (NASDAQ:UROY – Get Free Report) is projected to post its quarterly earnings results before the market opens on Friday, March 21st. Analysts expect Uranium Royalty to post earnings of ($0.01) per share and revenue of $12.40 million for the quarter.
Uranium Royalty (NASDAQ:UROY – Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). On average, analysts expect Uranium Royalty to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Uranium Royalty Stock Up 5.9 %
UROY stock opened at $1.96 on Thursday. Uranium Royalty has a 52 week low of $1.57 and a 52 week high of $3.12. The company has a market cap of $261.93 million, a price-to-earnings ratio of 65.36 and a beta of 1.17. The business has a fifty day simple moving average of $2.18 and a 200-day simple moving average of $2.37.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on Uranium Royalty
About Uranium Royalty
Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.
Read More
- Five stocks we like better than Uranium Royalty
- Compound Interest and Why It Matters When Investing
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Best Stocks Under $10.00
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Invest in Biotech Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.